Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000538455 | SCV000632595 | benign | Carnitine palmitoyltransferase II deficiency | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000594905 | SCV000707881 | likely benign | not specified | 2017-04-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002516965 | SCV003718553 | likely benign | Inborn genetic diseases | 2022-06-03 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV003456007 | SCV004178288 | likely benign | Encephalopathy, acute, infection-induced, susceptibility to, 4 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003454486 | SCV004178289 | likely benign | Carnitine palmitoyl transferase II deficiency, severe infantile form | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003454488 | SCV004178290 | likely benign | Carnitine palmitoyl transferase II deficiency, neonatal form | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003454487 | SCV004178291 | likely benign | Carnitine palmitoyl transferase II deficiency, myopathic form | 2023-04-11 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV003736627 | SCV004562053 | likely benign | not provided | 2023-10-03 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003927722 | SCV004739738 | likely benign | CPT2-related disorder | 2019-06-19 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Natera, |
RCV000538455 | SCV001456153 | likely benign | Carnitine palmitoyltransferase II deficiency | 2020-01-11 | no assertion criteria provided | clinical testing |